Ani Pharmaceuticals (ANIP) Debt Ratio (2012 - 2026)

Ani Pharmaceuticals (ANIP) has 15 years of Debt Ratio data on file, last reported at 0.21 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 12.32% year-over-year to 0.21; the trailing twelve-month figure through Mar 2026 stood at 0.21 (down 12.32% YoY), and the FY2025 full-year result was 0.21, down 13.39% from the prior year.
• Debt Ratio was little changed at 0.21 in Q1 2026, from 0.21 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.39 in Q3 2022 to a low of 0.21 in Q4 2025.
• A 5-year average of 0.3 and a median of 0.31 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio grew 0.91% in 2022 and decreased 27.42% in 2025, its largest moves.
• Tracing ANIP's Debt Ratio over 5 years: stood at 0.38 in 2022, then decreased by 12.6% to 0.33 in 2023, then declined by 24.56% to 0.25 in 2024, then retreated by 13.39% to 0.21 in 2025, then increased by 0.04% to 0.21 in 2026.
• Business Quant data shows ANIP's Debt Ratio at 0.21 in Q1 2026, 0.21 in Q4 2025, and 0.22 in Q3 2025.